SK BIOPHARMACEUTICALS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 89,600 KRW | 0.00% |
|
-0.22% | -10.76% |
| May. 10 | SK Biopharmaceuticals Turns to Profit in Q1 as Sales Jump 88% | MT |
| Jan. 30 | SK Biopharmaceuticals Swings to Profit in Q4 | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 492B 364M | Sales 2025 * | 644B 476M | Capitalization | 7,017B 5.19B |
|---|---|---|---|---|---|
| Net income 2024 * | 36B 26.64M | Net income 2025 * | 117B 86.58M | EV / Sales 2024 * | 14 x |
| Net cash position 2024 * | 145B 107M | Net cash position 2025 * | 218B 161M | EV / Sales 2025 * | 10.6 x |
| P/E ratio 2024 * |
186
x | P/E ratio 2025 * |
56
x | Employees | 252 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 35.75% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 week | -0.22% | ||
| Current month | +2.28% | ||
| 1 month | +6.16% | ||
| 3 months | +4.92% | ||
| 6 months | +4.55% | ||
| Current year | -10.76% |
1 week
87 300.00
90 500.00
1 month
82 600.0092 000.00
Current year
80 700.00104 800.00
1 year
70 900.00104 800.00
3 years
50 900.00137 500.00
5 years
50 900.00269 500.00
10 years
50 900.00269 500.00
| Managers | Title | Age | Since |
|---|---|---|---|
Dong-Hoon Lee
CEO | Chief Executive Officer | 56 | 22-12-31 |
Choi Jonggil
PRN | Corporate Officer/Principal | - | 22-12-31 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 17-03-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Geun-Joo Hwang
BRD | Director/Board Member | 60 | 17-03-15 |
Jeong-Woo Jo
PRN | Corporate Officer/Principal | - | 17-03-15 |
Young-Ju Bang
BRD | Director/Board Member | - | 19-08-26 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.83% | 2 M€ | -14.14% | ||
| 0.08% | 15 M€ | +18.83% | ||
| 0.03% | 2,867 M€ | +11.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 89,600 | 0.00% | 73,206 |
| 24-05-16 | 89,600 | +2.40% | 67,761 |
| 24-05-14 | 87,500 | -1.24% | 58,199 |
| 24-05-13 | 88,600 | -1.34% | 43,862 |
| 24-05-10 | 89,800 | +1.58% | 113,931 |
End-of-day quote Korea S.E., May 16, 2024
More quotes
SK Biopharmaceuticals Co Ltd is a Korea-based company mainly engages in the development and manufacture of pharmaceuticals. The Company mainly develops and produces pharmaceuticals including epilepsy drugs, sleep disorder drugs, rare neurological disorder drugs, concentration disorder drugs, schizophrenia drugs, and bipolar disorder drugs, among others. The Company also engages in the new drug development business.
Sector
Pharmaceuticals
Calendar
2024-08-14
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
89,600
KRW
Average target price
106,400
KRW
Spread / Average Target
+18.75%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -10.76% | 5.19B | |
| +10.23% | 8.96B | |
| +51.58% | 4.77B | |
| +12.50% | 4.26B | |
| -20.70% | 2.37B | |
| +12.83% | 2.3B | |
| -29.65% | 2.21B | |
| +19.51% | 2.17B | |
| -0.50% | 1.64B | |
| +0.55% | 1.6B |
- Stock Market
- Equities
- A326030 Stock
